TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
1.150
+0.010 (0.88%)
At close: Dec 5, 2025, 4:00 PM EST
1.170
+0.020 (1.74%)
After-hours: Dec 5, 2025, 6:40 PM EST
TELA Bio Stock Forecast
Stock Price Forecast
The 4 analysts that cover TELA Bio stock have a consensus rating of "Strong Buy" and an average price target of $3.31, which forecasts a 187.83% increase in the stock price over the next year. The lowest target is $1.25 and the highest is $5.00.
Price Target: $3.31 (+187.83%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for TELA Bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 1 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 3 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Strong Buy Maintains $6 → $3 | Strong Buy | Maintains | $6 → $3 | +160.87% | Dec 1, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $7 → $4 | Strong Buy | Maintains | $7 → $4 | +247.83% | Nov 18, 2025 |
| Piper Sandler | Piper Sandler | Hold Reiterates $2 → $1.25 | Hold | Reiterates | $2 → $1.25 | +8.70% | Nov 14, 2025 |
| Citizens | Citizens | Buy Maintains $7 → $5 | Buy | Maintains | $7 → $5 | +334.78% | Nov 14, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $12 → $7 | Strong Buy | Maintains | $12 → $7 | +508.70% | Mar 21, 2025 |
Financial Forecast
Revenue This Year
82.04M
from 69.30M
Increased by 18.39%
Revenue Next Year
94.62M
from 82.04M
Increased by 15.34%
EPS This Year
-0.85
from -1.33
EPS Next Year
-0.60
from -0.85
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 84.5M | 97.7M | ||
| Avg | 82.0M | 94.6M | ||
| Low | 78.8M | 90.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 22.0% | 19.0% | ||
| Avg | 18.4% | 15.3% | ||
| Low | 13.7% | 10.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -0.85 | -0.52 | ||
| Avg | -0.85 | -0.60 | ||
| Low | -0.83 | -0.67 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | - | ||
| Avg | - | - | ||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.